Receive our Where Oncology Practices are Losing the Most Money White Paper
Oncology practices operate in one of the most financially complex environments in healthcare. High-cost drugs, evolving payer rules, prior authorization requirements, and chronic staffing shortages have turned revenue cycle management (RCM) into a strategic risk area – not just an operational function.
Yet many oncology practices continue to lose significant revenue quietly and consistently, without clear visibility into where or why it’s happening.
This white paper examines the three primary sources of revenue loss in oncology RCM:
- Drug underpayments
- Denials and write-offs
- Lack of payer performance visibility
It also explores how modern oncology leaders are using automation, analytics, and centralized intelligence, specifically through ImagineOne®, to uncover hidden losses, reduce risk, and build
financial resilience.
